Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres

K-Number: K173871 · 2018-09-17

Decision Date2018-09-17
Product CodeNAJ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres is the device name listed in this FDA 510(k) record. The listed applicant is Suzhou Hengrui Callisyn Biomedical Co., Ltd.. It received FDA 510(k) clearance on 2018-09-17 under 510(k) number K173871. The device is classified under product code NAJ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres?

CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres is a medical device that received FDA 510(k) clearance on 2018-09-17. The listed applicant is Suzhou Hengrui Callisyn Biomedical Co., Ltd.. The 510(k) number is K173871.

When did CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres receive FDA 510(k) clearance?

CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres received FDA 510(k) clearance on 2018-09-17, under 510(k) number K173871.

Who is the listed applicant for CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres?

The FDA 510(k) record lists Suzhou Hengrui Callisyn Biomedical Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres?

The FDA product code for CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres is NAJ.

Related Devices (Code: NAJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.